1. Orlando, Francesca, Naddei, Roberta, Stellacci, Emilia, Tartaglia, Marco, Alessio, Maria. 2021. Etanercept as a successful therapy in autoinflammatory syndrome related to TRNT1 mutations: a case-based review. In Clinical rheumatology, 40, 4341-4348. doi:10.1007/s10067-021-05653-3. https://pubmed.ncbi.nlm.nih.gov/33646446/
2. Chakraborty, Pranesh K, Schmitz-Abe, Klaus, Kennedy, Erin K, Holcik, Martin, Fleming, Mark D. 2014. Mutations in TRNT1 cause congenital sideroblastic anemia with immunodeficiency, fevers, and developmental delay (SIFD). In Blood, 124, 2867-71. doi:10.1182/blood-2014-08-591370. https://pubmed.ncbi.nlm.nih.gov/25193871/
3. Li, Yan, Deng, Mengyue, Han, Tongxin, Mo, Wenxiu, Mao, Huawei. 2023. Thalidomide as an Effective Treatment in Sideroblastic Anemia, Immunodeficiency, Periodic Fevers, and Developmental Delay (SIFD). In Journal of clinical immunology, 43, 780-793. doi:10.1007/s10875-023-01441-7. https://pubmed.ncbi.nlm.nih.gov/36729249/
4. DeLuca, Adam P, Whitmore, S Scott, Barnes, Jenna, Stone, Edwin M, Slusarski, Diane C. 2015. Hypomorphic mutations in TRNT1 cause retinitis pigmentosa with erythrocytic microcytosis. In Human molecular genetics, 25, 44-56. doi:10.1093/hmg/ddv446. https://pubmed.ncbi.nlm.nih.gov/26494905/
智鼠故事 
